← FDA Drug Approvals (Drugs@FDA)

ERMEZA

NDA · New Drug Application · Sponsor: MYLAN · Approved 2022-04-29

Drug application

FDA Application #

NDA215809

Application type

New Drug Application

Brand name

ERMEZA

Generic name

LEVOTHYROXINE SODIUM

Active ingredients

LEVOTHYROXINE SODIUM

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

MYLAN

Manufacturer

Viatris Specialty LLC

First approval

2022-04-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown